David Domzalski - 31 Dec 2025 Form 4 Insider Report for VYNE Therapeutics Inc. (VYNE)

Role
PRESIDENT AND CEO, Director
Signature
/s/ Mutya Harsch, Attorney-in-Fact
Issuer symbol
VYNE
Transactions as of
31 Dec 2025
Net transactions value
-$7,358
Form type
4
Filing time
05 Jan 2026, 08:30:40 UTC
Previous filing
02 Oct 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Domzalski David PRESIDENT AND CEO, Director C/O VYNE THERAPEUTICS INC., P.O. BOX 125, STEWARTSVILLE /s/ Mutya Harsch, Attorney-in-Fact 05 Jan 2026 0001727794

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VYNE Common Stock Tax liability $7,358 -12,684 -3% $0.5801 416,208 31 Dec 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.